Richard F. Pops - Feb 26, 2024 Form 4 Insider Report for Alkermes plc. (ALKS)

Signature
/s/ Jeffrey Geary, attorney-in-fact for Richard F. Pops
Stock symbol
ALKS
Transactions as of
Feb 26, 2024
Transactions value $
$2,181,715
Form type
4
Date filed
2/27/2024, 04:02 PM
Previous filing
Feb 22, 2024
Next filing
Mar 12, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALKS Employee Stock Option (Right to Buy) Other $213K +4.6K +2% $46.24 235K Nov 17, 2023 Ordinary Shares 4.6K $46.24 Direct F1, F2
transaction ALKS Employee Stock Option (Right to Buy) Other $279K +4K +2% $69.83 204K Nov 17, 2023 Ordinary Shares 4K $69.83 Direct F1, F2
transaction ALKS Employee Stock Option (Right to Buy) Other $190K +6K +2% $31.64 306K Nov 17, 2023 Ordinary Shares 6K $31.64 Direct F1, F2
transaction ALKS Employee Stock Option (Right to Buy) Other $214K +4K +2% $53.50 204K Nov 17, 2023 Ordinary Shares 4K $53.50 Direct F1, F2
transaction ALKS Employee Stock Option (Right to Buy) Other $389K +5.9K +2% $65.94 301K Nov 17, 2023 Ordinary Shares 5.9K $65.94 Direct F1, F2
transaction ALKS Employee Stock Option (Right to Buy) Other $77.2K +2.42K +2% $31.93 123K Nov 17, 2023 Ordinary Shares 2.42K $31.93 Direct F1, F2
transaction ALKS Employee Stock Option (Right to Buy) Other $244K +7.64K +2% $31.93 390K Nov 17, 2023 Ordinary Shares 7.64K $31.93 Direct F1, F3
transaction ALKS Employee Stock Option (Right to Buy) Other $144K +7.17K +2% $20.03 366K Nov 17, 2023 Ordinary Shares 7.17K $20.03 Direct F1, F4
transaction ALKS Employee Stock Option (Right to Buy) Other $132K +6.84K +2% $19.34 349K Nov 17, 2023 Ordinary Shares 6.84K $19.34 Direct F1, F5
transaction ALKS Employee Stock Option (Right to Buy) Other $147K +5.98K +2% $24.59 305K Nov 17, 2023 Ordinary Shares 5.98K $24.59 Direct F1, F6
transaction ALKS Employee Stock Option (Right to Buy) Other $153K +5.7K +2% $26.82 291K Nov 17, 2023 Ordinary Shares 5.7K $26.82 Direct F1, F7
transaction ALKS Employee Stock Option (Right to Buy) Award $0 +274K $0.00 274K Feb 26, 2024 Ordinary Shares 274K $30.04 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the "Separation"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5.
F2 These options are fully vested in accordance with their terms.
F3 Shares underlying the stock option award shall not vest and become exercisable unless and until the closing price of an ordinary share of Alkermes plc, as reported by the Nasdaq Global Select Market or another national securities exchange on which Alkermes plc's ordinary shares are listed, is fifty U.S. Dollars (US$50.00) or higher for thirty (30) consecutive trading days during the term of the award (the "performance criteria"). Subject to achievement of the performance criteria, the shares underlying the stock option award shall vest in four equal annual installments commencing on 2/21/2020. This award expires ten years from the date of grant.
F4 Shares subject to the stock option award vest and become exercisable in four equal annual installments commencing on 2/20/2021.
F5 Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/22/2022.
F6 Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/18/2023.
F7 Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/23/2024.
F8 Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/26/2025.

Remarks:

EXHIBIT LIST: Exhibit 24.1 - Power of Attorney